Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Wiewrodt

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Emerging Microbes & Infections|December 13, 2019
Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activitiesAline da Rocha Matos, Katharina Wunderlich, Sebastian Schloer, et al.
Antiviral Research|November 24, 2022
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrierAileen Faist, Sebastian Schloer, Angeles Mecate-Zambrano, et al.
The European Respiratory Journal|March 25, 2014
The European initiative for quality management in lung cancer careTorsten G Blum, Anna Rich, David Baldwin, et al.
Nature|March 14, 2024
Evolutionary trajectories of small cell lung cancer under therapyJulie George, Lukas Maas, Nima Abedpour, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Emerging Microbes & Infections|December 13, 2019
Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activitiesAline da Rocha Matos, Katharina Wunderlich, Sebastian Schloer, et al.
Antiviral Research|November 24, 2022
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrierAileen Faist, Sebastian Schloer, Angeles Mecate-Zambrano, et al.
The European Respiratory Journal|March 25, 2014
The European initiative for quality management in lung cancer careTorsten G Blum, Anna Rich, David Baldwin, et al.
Nature|March 14, 2024
Evolutionary trajectories of small cell lung cancer under therapyJulie George, Lukas Maas, Nima Abedpour, et al.
Pageof 7